Status:
COMPLETED
Effects of Oxymizer Pendant Cannula Versus Conventional Nasal Cannula During Endurance Shuttle Walk Tests in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis
Lead Sponsor:
Klaus Kenn
Collaborating Sponsors:
Schön Klinik Berchtesgadener Land
Conditions:
Idiopathic Pulmonary Fibrosis
Hypoxemia
Eligibility:
All Genders
Phase:
NA
Brief Summary
Aim of this study is to investigate the effects of an Oxymizer pendant nasal cannula in hypoxemic patients with idiopathic pulmonary fibrosis during walking.
Detailed Description
Patients will be recruited during an inpatient pulmonary rehabilitation program. They will perform three shuttle walk tests on three consecutive days (see below). While performing those tests, the pat...
Eligibility Criteria
Inclusion
- firmed diagnosis of idiopathic pulmonary fibrosis
- indication for supplemental oxygen therapy during exercise
- referred to an inpatient rehabilitation program at the Schön Klinik Berchtesgadener Land
Exclusion
- cardiovascular diseases that influence the patient's physical performance
- orthopedic comorbidities that prevent the patient from performing an incremental or endurance shuttle walk test
- carbon dioxide pressure above 45 mmHg at rest and ambient air
Key Trial Info
Start Date :
January 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2019
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT03411876
Start Date
January 18 2018
End Date
January 15 2019
Last Update
April 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schön Klinik Berchtesgadener Land
Schönau am Königssee, Germany